FilingSEC EDGAR8-K
Niki BioSolutions Appoints New CEO and COO
· SEC accepted
StageExecutive Appointment
Filing content
As part of the merger transaction, the company appointed Ian Huen as CEO and Alidad Mireskandari as President and COO, entering into employment agreements with both.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…